Two decades of progress in preventing vascular disease

被引：285

作者：

Yusuf, S ^{[1
]}

机构：

[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada

来源：

LANCET | 2002年 / 360卷 / 9326期

关键词：

D O I：

10.1016/S0140-6736(02)09358-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 3

页数：2

共 10 条

[1]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[2]

Law M, 1998, EVIDENCE BASED CARDI, P191

[3]

PECHACEK TF, 1998, EVIDENCE BASED CARDI, P165

[4]

PEDERSEN TR, 1994, LANCET, V344, P1383

[5] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[6]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

[7] Global burden of cardiovascular diseases - Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization [J].

Yusuf, S ;

Reddy, S ;

Ounpuu, S ;

Anand, S .

CIRCULATION, 2001, 104 (22) :2746-2753

[8] BETA-BLOCKADE DURING AND AFTER MYOCARDIAL-INFARCTION - AN OVERVIEW OF THE RANDOMIZED TRIALS [J].

YUSUF, S ;

PETO, R ;

LEWIS, J ;

COLLINS, R ;

SLEIGHT, P .

PROGRESS IN CARDIOVASCULAR DISEASES, 1985, 27 (05) :335-371

[9]

Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302

[10]

Yusuf S, 2000, NEW ENGL J MED, V342, P145

← 1 →